In 2012, CanSORT received a $13 million program award from the National Cancer Institute to study the challenges of individualizing treatments for patients with breast cancer. A key part of this program was the Individualized Cancer Care Study (iCanCare Study). We surveyed over 5000 women newly diagnosed with early-stage breast cancer in 2013-15 to better understand their experiences during their initial breast cancer treatment.
Recently, CanSORT received a Research Scholar Grant from the American Cancer Society to continue the iCanCare Study. The goal of the iCanCare Follow-up Study is to investigate disparities in the quality and delivery of survivorship care. A sample of women who participated in the baseline iCanCare study will be surveyed again about the care they are receiving six years post-diagnosis.
Individual participants cannot be identified in the study data, and survey responses are never shared between participants and their doctors.
Below are some frequently-asked questions about the baseline iCanCare Study and the current iCanCare Follow-Up Study. Please click on each topic to learn more.
Frequently Asked Questions
Who is funding the study?
Who are the primary investigators?
How are women selected for participation?
How many women are participating?
What are participants asked to do?
What will the researchers do with the information from the study?
How long does the study last?
Who can I contact if I have a question?
What are my rights as a research subject and what will happen if I decide not to participate?
How did you get my name and contact information?
What if I don't want to answer a question?
How will you keep my information confidential?